126 related articles for article (PubMed ID: 2173043)
1. Controversies in the management of non-small cell lung cancer: the results of an expert surrogate study.
Palmer MJ; O'Sullivan B; Steele R; Mackillop WJ
Radiother Oncol; 1990 Sep; 19(1):17-28. PubMed ID: 2173043
[TBL] [Abstract][Full Text] [Related]
2. The use of expert surrogates to evaluate clinical trials in non-small cell lung cancer.
Mackillop WJ; Ward GK; O'Sullivan B
Br J Cancer; 1986 Oct; 54(4):661-7. PubMed ID: 3022780
[TBL] [Abstract][Full Text] [Related]
3. Clinical trials in cancer: the role of surrogate patients in defining what constitutes an ethically acceptable clinical experiment.
Mackillop WJ; Palmer MJ; O'Sullivan B; Ward GK; Steele R; Dotsikas G
Br J Cancer; 1989 Mar; 59(3):388-95. PubMed ID: 2930704
[TBL] [Abstract][Full Text] [Related]
4. Does knowledge guide practice? Another look at the management of non-small-cell lung cancer.
Raby B; Pater J; Mackillop WJ
J Clin Oncol; 1995 Aug; 13(8):1904-11. PubMed ID: 7636532
[TBL] [Abstract][Full Text] [Related]
5. Non-small cell lung cancer: how oncologists want to be treated.
Mackillop WJ; O'Sullivan B; Ward GK
Int J Radiat Oncol Biol Phys; 1987 Jun; 13(6):929-34. PubMed ID: 3034842
[TBL] [Abstract][Full Text] [Related]
6. Treatment dilemmas in "non-small cell" lung cancer.
Sørensen JB; Hansen HH
Radiother Oncol; 1990 Sep; 19(1):89. PubMed ID: 2173045
[No Abstract] [Full Text] [Related]
7. Japanese doctors' preferred treatment choices for their hypothetical non-small cell lung cancer: how they would wish to be treated. National Chest Hospital Study Group for Lung Cancer.
Motohiro A; Hirota N; Komatsu H; Yanai N
Lung Cancer; 1994 Jul; 11(1-2):43-50. PubMed ID: 7521732
[TBL] [Abstract][Full Text] [Related]
8. Approach to the non-operative management of patients with stage II non-small cell lung cancer (NSCLC): A survey of Canadian medical and radiation oncologists.
Dudani S; Leighl NB; Ho C; Pantarotto JR; Zhu X; Zhang T; Wheatley-Price P
Lung Cancer; 2016 Apr; 94():74-80. PubMed ID: 26973210
[TBL] [Abstract][Full Text] [Related]
9. How expert physicians would wish to be treated if they had genitourinary cancer.
Moore MJ; O'Sullivan B; Tannock IF
J Clin Oncol; 1988 Nov; 6(11):1736-45. PubMed ID: 3054004
[TBL] [Abstract][Full Text] [Related]
10. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.
J Clin Oncol; 1997 Aug; 15(8):2996-3018. PubMed ID: 9256144
[TBL] [Abstract][Full Text] [Related]
11. Lung cancer treatment in New Zealand: physician's attitudes.
Christmas T; Findlay M
N Z Med J; 2004 Jun; 117(1196):U931. PubMed ID: 15280935
[TBL] [Abstract][Full Text] [Related]
12. Survey on the treatment of non-small cell lung cancer (NSCLC) in England and Wales.
Crook A; Duffy A; Girling DJ; Souhami RL; Parmar MK
Eur Respir J; 1997 Jul; 10(7):1552-8. PubMed ID: 9230246
[TBL] [Abstract][Full Text] [Related]
13. Beliefs among pulmonologists and thoracic surgeons in the therapeutic approach to non-small cell lung cancer.
Schroen AT; Detterbeck FC; Crawford R; Rivera MP; Socinski MA
Chest; 2000 Jul; 118(1):129-37. PubMed ID: 10893370
[TBL] [Abstract][Full Text] [Related]
14. Are treatment strategies of urologic oncologists influenced by the opinions of their colleagues?
Moore MJ; O'Sullivan B; Tannock IF
Br J Cancer; 1990 Dec; 62(6):988-91. PubMed ID: 2257231
[TBL] [Abstract][Full Text] [Related]
15. Patients' and doctors' preferences for adjuvant chemotherapy in resected non-small-cell lung cancer: What makes it worthwhile?
Blinman P; Hughes B; Crombie C; Christmas T; Hudson M; Veillard AS; Muljadi N; Millward M; Wright G; Flynn P; Windsor M; Stockler M; McLachlan SA;
Eur J Cancer; 2015 Aug; 51(12):1529-37. PubMed ID: 26059196
[TBL] [Abstract][Full Text] [Related]
16. A systematic review and Canadian consensus recommendations on the use of biomarkers in the treatment of non-small cell lung cancer.
Ellis PM; Blais N; Soulieres D; Ionescu DN; Kashyap M; Liu G; Melosky B; Reiman T; Romeo P; Shepherd FA; Tsao MS; Leighl NB
J Thorac Oncol; 2011 Aug; 6(8):1379-91. PubMed ID: 21709590
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and therapeutic approaches to lung cancer in Canada and their costs.
Evans WK; Will BP; Berthelot JM; Wolfson MC
Br J Cancer; 1995 Nov; 72(5):1270-7. PubMed ID: 7577481
[TBL] [Abstract][Full Text] [Related]
18. Tumor board participation among physicians caring for patients with lung or colorectal cancer.
Kehl KL; Landrum MB; Kahn KL; Gray SW; Chen AB; Keating NL
J Oncol Pract; 2015 May; 11(3):e267-78. PubMed ID: 25922221
[TBL] [Abstract][Full Text] [Related]
19. Clinical cancer research--some aspects on doctors' attitudes to informing participants.
Lynöe N; Sandlund M; Jacobsson L
Acta Oncol; 1996; 35(6):749-54. PubMed ID: 8938225
[TBL] [Abstract][Full Text] [Related]
20. Exercise intervention to improve exercise capacity and health related quality of life for patients with Non-small cell lung cancer: a systematic review.
Granger CL; McDonald CF; Berney S; Chao C; Denehy L
Lung Cancer; 2011 May; 72(2):139-53. PubMed ID: 21316790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
